A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

608

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

February 3, 2025

Study Completion Date

January 30, 2026

Conditions
Hidradenitis Suppurativa (HS)
Interventions
DRUG

Povorcitinib

Oral; Tablet

DRUG

Placebo

Oral; Tablet

Trial Locations (104)

11415

Investigative Site US324, Kew Gardens

12462

Investigative Site GR300, Athens

13385

Investigative Site FR304, Marseille

15706

Investigative Site ES304, Santiago de Compostela

16121

Investigative Site GR303, Athens

18014

Investigative Site ES301, Granada

20246

Investigative Site DE303, Hamburg

21045

Investigative Site US325, Columbia

21287

Investigative Site US333, Baltimore

23502

Investigative Site US313, Norfolk

28041

Investigative Site ES305, Madrid

29609

Investigative Site FR303, Brest

30519

Investigative Site DE300, Hanover

31059

Investigative Site FR306, Toulouse

32819

Investigative Site US316, Orlando

33000

Investigative Site FR305, Bordeaux

33063

Investigative Site US338, Margate

33486

Investigative Site US306, Boca Raton

Investigative Site US320, Boca Raton

33612

Investigative Site US328, Tampa

33613

Investigative Site US336, Tampa

36001

Investigative Site ES300, Pontevedra

40225

Investigative Site DE306, Düsseldorf

42103

Investigative Site US341, Bowling Green

42270

Investigative Site FR301, Saint-Priest-en-Jarez

43209

Investigative Site US339, Bexley

44093

Investigative Site FR302, Nantes

44106

Investigative Site US312, Cleveland

44512

Investigative Site US330, Boardman

45219

Investigative Site US314, Cincinnati

46250

Investigative Site US337, Indianapolis

54643

Investigative Site GR301, Thessaloniki

56403

Investigative Site GR302, Thessaloniki

60077

Investigative Site US319, Skokie

60590

Investigative Site DE301, Frankfurt am Main

60612

Investigative Site US327, Chicago

63110

Investigative Site US302, St Louis

64283

Investigative Site DE305, Darmstadt

70006

Investigative Site US334, Metairie

72037

Investigative Site FR307, Le Mans

72758

Investigative Site US335, Arkansas City

72916

Investigative Site US307, Fort Smith

75010

Investigative Site FR300, Paris

75025

Investigative Site US300, Plano

77401

Investigative Site US340, Bellaire

85006

Investigative Site US303, Phoenix

87102

Investigative Site US331, Albuquerque

87700

Investigative Site DE307, Memmingen

89129

Investigative Site DE304, Langenau

90045

Investigative Site US326, Los Angeles

92677

Investigative Site US315, Laguna Niguel

94118

Investigative Site US323, San Francisco

97223

Investigative Site US301, Portland

99202

Investigative Site US308, Spokane

33012-3618

Investigative Site US317, Hialeah

33162-4708

Investigative Site US321, North Miami Beach

30060-1047

Investigative Site US311, Marietta

01915

Investigative Site US318, Beverly

02215

Investigative Site US304, Boston

02135

Investigative Site US310, Brighton

08036

Investigative Site AT304, Graz

06020

Investigative Site 00A, Innsbruck

Investigative Site AT306, Innsbruck

04020

Investigative Site AT302, Linz

01090

Investigative Site AT305, Vienna

01100

Investigative Site AT301, Vienna

01130

Investigative Site AT300, Vienna

01070

Investigative Site BE300, Brussels

01200

Investigative Site BE304, Brussels

09000

Investigative Site BE301, Ghent

Investigative Site BE306, Ghent

03000

Investigative Site BE305, Leuven

04000

Investigative Site BE302, Liège

05000

Investigative Site BE303, Namur

R3M 3Z4

Investigative Site CA301, Winnipeg

L4M 1G7

Investigative Site CA304, Barrie

L8L 3C3

Investigative Site CA308, Hamilton

N6H 5L5

Investigative Site CA303, London

K9J 5K2

Investigative Site CA302, Peterborough

H7N 6L2

Investigative Site CA306, Laval

H2K 4L5

Investigative Site CA307, Montreal

G1V 4T3

Investigative Site CA309, Québec

708 52

Investigative Site CZ301, Ostrava - Poruba

150 06

Investigative Site CZ300, Prague

01307

Investigative Site DE302, Dresden

173-8610

Investigative Site JP304, Itabashi-ku

830-0011

Investigative Site JP305, Kurume-shi

602-8566

Investigative Site JP300, Kyoto

903-0215

Investigative Site JP301, Nakagami-gun

951-8520

Investigative Site JP303, Niigata

663-8186

Investigative Site JP307, Nishinomiya-shi

060-8648

Investigative Site JP308, Sapporo

980-8574

Investigative Site JP302, Sendai

160-0023

Investigative Site JP309, Shinjuku-ku

305-8576

Investigative Site JP306, Tsukuba

4818 CK

Investigative Site NL302, Breda

9713 GZ

Investigative Site NL303, Groningen

3015 GD

Investigative Site NL301, Rotterdam

27-400

Investigative Site PL304, Ostrowiec

60-529

Investigative Site PL303, Poznan

50-566

Investigative Site PL301, Wroclaw

51-318

Investigative Site PL302, Wroclaw

08916

Investigative Site ES302, Badalona

08003

Investigative Site ES303, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY